Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07579325 · ClinicalTrials.gov registry record
Lipid Screening Study
A clinical trial, sponsored by University of Central Florida.
- Recruiting
- Registry status
- 30
- Enrollment target
NCT07579325: Recruiting study, sponsored by University of Central Florida.
NCT07579325 is a clinical trial that is actively recruiting participants, run by University of Central Florida. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07579325 is actively recruiting participants, sponsored by University of Central Florida.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to estimate the prevalence of elevated Lipoprotein (a) in an adult primary care population and to describe the distribution of atherogenic lipid markers within this cohort. This pilot study will provide preliminary data to inform future cardiovascular risk assessment initiatives in primary care.
Primary Outcome
The purpose of this pilot study is to estimate the prevalence of elevated Lipoprotein (a) in an adult primary care population and to describe the distribution of atherogenic lipid markers within this cohort. This pilot study will provide preliminary data to inform future cardiovascular risk assessment initiatives in primary care.
Interventions
- OTHER Venipuncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-05-05 |
| Est. Completion | 2026-08-01 |
What NCT07579325 shows while recruiting
NCT07579325 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Venipuncture is the first listed.
NCT07579325 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07579325 about?
NCT07579325 is a clinical study titled "Lipid Screening Study". The purpose of this pilot study is to estimate the prevalence of elevated Lipoprotein (a) in an adult primary care population and to describe the distribution of atherogenic lipid markers within this cohort. This pilot study will provide preliminary data to inform future cardiovascular risk assessme...
What is the current status of trial NCT07579325?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2026-05-05. Estimated completion is 2026-08-01.
What interventions are being tested in trial NCT07579325?
The interventions under investigation include: Venipuncture (OTHER).
Who is sponsoring clinical trial NCT07579325?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI